Compare Ford Motor Company (F) vs Incyte Corporation (INCY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ford Motor Company vs Incyte Corporation — how do they compare? Ford Motor Company trades at $13.97 (market cap $55.83B), while Incyte Corporation trades at $120.45 (market cap $24.65B). The key difference: Ford Motor Company is far larger — about 2.3× Incyte Corporation's market cap, and Ford Motor Company pays a 4.29% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| F | INCY | |
|---|---|---|
Market Cap | $55.83B | $24.65B |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $129.93 |
52-Week Low | $11.21 | $81.61 |
Enterprise Value | $187.79B | $20.15B |
Dividend Yield | 4.29% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →
